Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Axsome Therapeutics Stock Ready to Rebound?

TheMotleyFool

0 0

Is Axsome Therapeutics Stock Ready to Rebound?Photo, wide shot, wide-angle lens, Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png

Axsome Therapeutics (NASDAQ: AXSM) has been a beaten-down biotech stock throughout much of this year. In this Motley Fool Live video recorded on Aug. 4, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not there's upside potential for the stock going forward. (Note: This video was recorded before Axsome announced that the U.S. Food and Drug Administration identified issues that delay an approval decision on AXS-05 in treating depression.)

Source Fool.com

Like: 0

AXSM

Teilen